ESPR Stock-Based Compensation
Esperion Therapeutics Inc · Stock-Based Compensation
ESPR Stock-Based Compensation
Latest reported$2.50Mperiod ending
ESPR Quarterly Stock-Based Comp ($0.00 → $2.50M)
Quarterly stock-based compensation
High-resolution chart · PNG
ESPR stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 2,502,000 | |
| 2,387,000 | |
| 2,349,000 | |
| 2,669,000 | |
| 2,465,000 | |
| 2,805,000 | |
| 3,022,000 | |
| 2,931,000 | |
| 3,235,000 | |
| 2,920,000 | |
| 2,975,000 | |
| 3,160,000 | |
| 2,903,000 | |
| 3,715,000 | |
| 3,537,000 | |
| 3,527,000 | |
| 4,436,000 | |
| 4,474,000 | |
| 5,497,000 | |
| 8,584,000 | |
| 5,751,000 | |
| 6,673,000 | |
| 7,264,000 | |
| 7,395,000 | |
| 7,053,000 | |
| 6,358,000 | |
| 6,327,000 | |
| 6,563,000 | |
| 6,636,000 | |
| 6,829,000 | |
| 5,495,000 | |
| 5,723,000 | |
| 5,921,000 | |
| 4,534,000 | |
| 4,941,000 | |
| 4,980,000 | |
| 4,150,000 | |
| 3,571,000 | |
| 3,709,000 | |
| 4,121,000 | |
| 4,556,000 | |
| 4,385,000 | |
| 3,371,000 | |
| 2,898,000 | |
| 2,072,000 | |
| 1,053,000 | |
| 950,000 | |
| 935,000 | |
| 741,000 | |
| 553,744 | |
| 519,832 | |
| 98,440 | |
| 54,972 | |
| 19,283 | |
| 29,279 | |
| 15,157 | |
| 16,142 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |